Biosynex SA
PAR:ALBIO
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Biosynex SA
Operating Income
Biosynex SA
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Biosynex SA
PAR:ALBIO
|
Operating Income
-€8.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-23%
|
|
Edap Tms SA
NASDAQ:EDAP
|
Operating Income
-€19.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-72%
|
CAGR 10-Years
-22%
|
|
Biomerieux SA
PAR:BIM
|
Operating Income
€439m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Carmat SA
PAR:ALCAR
|
Operating Income
-€52.5m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-13%
|
|
Biocorp Production SA
PAR:ALCOR
|
Operating Income
-€732.1k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
Amplitude Surgical SA
PAR:AMPLI
|
Operating Income
€8.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
73%
|
CAGR 10-Years
N/A
|
See Also
What is Biosynex SA's Operating Income?
Operating Income
-8.9m
EUR
Based on the financial report for Dec 31, 2023, Biosynex SA's Operating Income amounts to -8.9m EUR.
What is Biosynex SA's Operating Income growth rate?
Operating Income CAGR 10Y
-23%